Surgery Faculty Publications

School of Medicine

11-1-2021

Intracorporeal and Extracorporeal Anastomosis for RoboticAssisted and Laparoscopic Right Colectomy: Short-Term
Outcomes of a Multi-Center Prospective Trial
Robert K. Cleary
St. Joseph Mercy Hospital

Matthew Silviera
Washington University School of Medicine in St. Louis

Tobi J. Reidy
Franciscan Health

James McCormick
West Penn Allegheny Health System

Craig
Johnson
FollowS.
this
and additional works at: https://digitalscholarship.unlv.edu/surgery_fac_articles
Oklahoma Surgical Hospital
Part of the Cancer Biology Commons, and the Surgery Commons
See next page for additional authors

Repository Citation

Cleary, R. K., Silviera, M., Reidy, T. J., McCormick, J., Johnson, C. S., Sylla, P., Cannon, J., Lujan, H., Kassir,
A., Landmann, R., Gaertner, W., Lee, E., Bastawrous, A., Bardakcioglu, O., Pandey, S., Attaluri, V. (2021).
Intracorporeal and Extracorporeal Anastomosis for Robotic-Assisted and Laparoscopic Right Colectomy:
Short-Term Outcomes of a Multi-Center Prospective Trial. Surgical Endoscopy 1-10.
Available at: http://dx.doi.org/10.1007/s00464-021-08780-9

This Article is protected by copyright and/or related rights. It has been brought to you by Digital Scholarship@UNLV
with permission from the rights-holder(s). You are free to use this Article in any way that is permitted by the
copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from
the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/
or on the work itself.
This Article has been accepted for inclusion in Surgery Faculty Publications by an authorized administrator of
Digital Scholarship@UNLV. For more information, please contact digitalscholarship@unlv.edu.

Authors
Robert K. Cleary, Matthew Silviera, Tobi J. Reidy, James McCormick, Craig S. Johnson, Patricia Sylla,
Jamie Cannon, Henry Lujan, Andrew Kassir, Ron Landmann, Wolfgang Gaertner, Edward Lee, Amir
Bastawrous, Ovunc Bardakcioglu, Sushil Pandey, and Vikram Attaluri

This article is available at Digital Scholarship@UNLV: https://digitalscholarship.unlv.edu/surgery_fac_articles/1

Surgical Endoscopy
https://doi.org/10.1007/s00464-021-08780-9

and Other Interventional Techniques

Intracorporeal and extracorporeal anastomosis for robotic‑assisted
and laparoscopic right colectomy: short‑term outcomes
of a multi‑center prospective trial
Robert K. Cleary1 · Matthew Silviera2 · Tobi J. Reidy3 · James McCormick4 · Craig S. Johnson5 · Patricia Sylla6 ·
Jamie Cannon7 · Henry Lujan8 · Andrew Kassir9 · Ron Landmann10 · Wolfgang Gaertner11 · Edward Lee12 ·
Amir Bastawrous13 · Ovunc Bardakcioglu14 · Sushil Pandey15 · Vikram Attaluri16 · Mitchell Bernstein17 ·
Vincent Obias18 · Morris E. Franklin Jr.19 · Alessio Pigazzi20
Received: 2 February 2021 / Accepted: 13 October 2021
© The Author(s) 2021

Abstract
Background Studies to date show contrasting conclusions when comparing intracorporeal and extracorporeal anastomoses
for minimally invasive right colectomy. Large multi-center prospective studies comparing perioperative outcomes between
these two techniques are needed. The purpose of this study was to compare intracorporeal and extracorporeal anastomoses
outcomes for robotic assisted and laparoscopic right colectomy.
Methods Multi-center, prospective, observational study of patients with malignant or benign disease scheduled for laparoscopic or robotic-assisted right colectomy. Outcomes included conversion rate, gastrointestinal recovery, and complication
rates.
Results There were 280 patients: 156 in the robotic assisted and laparoscopic intracorporeal anastomosis (IA) group and
124 in the robotic assisted and laparoscopic extracorporeal anastomosis (EA) group. The EA group was older (mean age
67 vs. 65 years, p = 0.05) and had fewer white (81% vs. 90%, p = 0.05) and Hispanic (2% vs. 12%, p = 0.003) patients. The
EA group had more patients with comorbidities (82% vs. 72%, p = 0.04) while there was no significant difference in individual comorbidities between groups. IA was associated with fewer conversions to open and hand-assisted laparoscopic
approaches (p = 0.007), shorter extraction site incision length (4.9 vs. 6.2 cm; p ≤ 0.0001), and longer operative time (156.9
vs. 118.2 min). Postoperatively, patients with IA had shorter time to first flatus, (1.5 vs. 1.8 days; p ≤ 0.0001), time to first
bowel movement (1.6 vs. 2.0 days; p = 0.0005), time to resume soft/regular diet (29.0 vs. 37.5 h; p = 0.0014), and shorter
length of hospital stay (median, 3 vs. 4 days; p ≤ 0.0001). Postoperative complication rates were comparable between groups.
Conclusion In this prospective, multi-center study of minimally invasive right colectomy across 20 institutions, IA was
associated with significant improvements in conversion rates, return of bowel function, and shorter hospital stay, as well as
significantly longer operative times compared to EA. These data validate current efforts to increase training and adoption of
the IA technique for minimally invasive right colectomy.
Keywords Robotic-assisted right colectomy · Laparoscopic right colectomy · Minimally invasive colorectal surgery ·
Intracorporeal anastomosis · Extracorporeal anastomosis
Minimally invasive options for ileocolonic anastomosis after
right colectomy include extracorporeal (EA) and intracorporeal (IA) anastomotic techniques. The extracorporeal approach
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Extended author information available on the last page of the article

is characterized by minimally invasive mobilization of the
diseased segment up through an extraction incision where
the anastomosis is then performed by standard open methods.
The extraction site for a right colectomy is typically the midline where the hernia rate is 8–12%, reportedly higher than
off-midline extraction site locations. [1, 2] Mobilization of
the transverse colon to reach the midline extraction site may
be a technical challenge, especially in obese individuals and
can result in the need to lengthen the incision. It may also
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result in increased bowel manipulation and mesenteric tears
and bleeding, possibly contributing to increased time to gastrointestinal recovery and postoperative ileus. [1]
In contrast to the extracorporeal technique, the intracorporeal
technique allows for less bowel manipulation and mobilization,
improved visualization for a critical part of the operation—the
anastomosis, and for the extraction site to be anywhere on the
abdominal wall or through a natural orifice, such as the vagina,
thereby avoiding the midline and potentially reducing the risk
for incisional hernia. [2, 3] The extraction incision size is limited only by the size of the diseased segment. Furthermore,
an intracorporeal anastomosis results in potential advantages,
including decreased conversion to an open operation, shorter
time to gastrointestinal recovery, decreased postoperative ileus,
and shorter length of hospital of stay. [1, 4–7]
Previous retrospective studies comparing extracorporeal and intracorporeal techniques for right colectomy have
reported inconclusive results, therefore prompting a need for
a prospective analysis. The aim of this prospective multicenter observational study was to evaluate outcomes of
intracorporeal and extracorporeal anastomoses using robotic
assisted and laparoscopic approaches to right colectomy.

Methods
This is a prospective, multi-center, observational study comparing intracorporeal and extracorporeal anastomoses for
right colectomy. Intracorporeal and extracorporeal anastomoses were completed either via a robotic assisted or a laparoscopic approach. The study was conducted in accordance
with institutional review board (IRB) guidelines and IRB
approval was obtained from each participating site. Eligible
patients from 20 participating institutions in the USA were
recruited beginning in February 2018.

Study design
This is an initial report of short-term outcomes up to 90 days
postoperative for the ANCOR (ANastomotic COmparison
in Right Colectomy) trial, a prospective study comparing
IA and EA anastomoses for minimally invasive right colectomy, with specimen extraction site incisional hernia as the
primary outcome.
Eligible patients were ≥ 18 years of age and scheduled to
undergo either laparoscopic or robotic-assisted right colectomy for benign or malignant right colon disease (proximal
to the mid transverse colon) with intracorporeal or extracorporeal anastomosis. Patients requiring emergent right colectomy and those with an obstructing, perforated, or locally
invasive neoplasm (T4b), inflammatory bowel disease, or
prior incisional hernia repair were excluded.
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Surgeon and operative details
Forty surgeons at 20 institutions contributed cases: 14
robotic-assisted IA surgeons, 5 laparoscopic IA surgeons,
16 laparoscopic EA surgeons, and 5 robotic-assisted EA
surgeons. To ensure adequate experience, surgeons at participating sites were required to have performed a minimum
of 50 right colectomies prior to contributing to a study arm.
Each surgeon was limited to one surgical approach (roboticassisted IA or robotic-assisted EA or laparoscopic IA or laparoscopic EA) and each surgeon was limited to contributing
no more than 20 cases to the study.
Right colectomy for malignancy adhered to standard
oncologic principles, although there were no strict criteria
for the extent of mesocolic excision. All robotic-assisted procedures were performed using multi-port techniques with a
da Vinci® Xi, X, or Si Surgical System.

Data collection
Case report forms were the primary data collection instruments for this study. Each study site entered clinical data into
an electronic case report form directly uploaded to a secure
centralized electronic clinical database (EDC). Data entry
quality was monitored by the study sponsor.
Data collected included patient demographics, operative details including operative and operating room times,
conversion to open or hand-assisted laparoscopic surgery,
anastomotic technique, concomitant general, colorectal,
urologic, and gynecologic procedures, and postoperative
outcomes, including complications, reoperation, and hospital readmission. Conversion was defined as the inability to
complete an EA or IA operation without converting to open
or hand-assisted laparoscopy for any reason or the need to
lengthen the extraction site incision more than expected for
the EA approach. The use of an enhanced recovery pathway,
mechanical bowel preparation with or without antibiotics,
anastomotic technique (iso- vs. anti-peristaltic, sutured vs.
stapled, and anastomotic reinforcement), as well as site and
length of the extraction incision were left to the discretion
of the operating surgeon. Operating room time was defined
as the time interval from when the patient entered the operating room to when the patient exited the operating room,
and operative time was defined as time from incision to skin
closure. Concomitant hepatic and other intestinal resections
(in addition to right colectomy) were excluded. Ileus was
defined as requiring a nasogastric tube. Data analysis was
performed on an intent-to-treat basis. Consequently, conversions were analyzed under the initial operative approach,
regardless of the reason for conversion.

Surgical Endoscopy

Statistical analysis
Standard univariate and bivariate techniques were used to
describe the clinical results. Continuous variables were
reported as means (and standard deviations) and median.
Discrete variables (i.e., conversions, complications) were
described as rates and proportions of totals. The chi-square or
Fisher’s exact test was used to compare categorical or binary
outcomes across groups. The independent t test was used for
approximately normally distributed continuous outcomes,
and the Wilcoxon Rank Sum test for ordinal and non-normal
continuous outcomes. A p-value of less than 0.05 was considered statistically significant. All analyses were performed
with SAS version 9.4 (SAS Institute, Inc. Cary, NC).

Results
Study population
Two-hundred and eighty patients met inclusion criteria and underwent minimally invasive right colectomy
(Fig. 1): 156 patients underwent intracorporeal anastomosis (125 robotic assisted and 31 laparoscopic) and
124 underwent extracorporeal anastomosis (30 robotic

assisted and 94 laparoscopic). Of the 156 IA cases, 90
(58%) were for malignant neoplasia and 66 (42%) were
for benign neoplasia. Of the 124 EA cases, 81 (66%) were
for malignant neoplasia, 42 (34%) were for benign neoplasia, and one patient had unknown tumor status. There
were no significant differences between groups for operative indications (p = 0.104).
Sixteen surgeons performed laparoscopic EA cases, 5
performed robotic-assisted EA cases, 14 performed roboticassisted IA cases, and 5 performed laparoscopic IA cases. Of
the 16 laparoscopic EA surgeons, 12 (75%) contributed less
than 10 cases and 4 (25%) contributed between 10 and 20
cases. Of the 5 robotic-assisted EA surgeons, 4 (80%) of the
surgeons contributed less than 10 cases and one (20%) contributed between 10 and 20 cases. Of the 14 robotic-assisted
IA surgeons, 9 (64%) of the surgeons contributed less than
10 cases and 5 (36%) contributed between 10 and 20 cases.
Of the 5 laparoscopic IA surgeons, 4 (80%) of the surgeons
contributed less than 10 cases and one (20%) contributed
between 10 and 20 cases.

Baseline characteristics
Table 1 shows patient characteristics for treatment groups.
There were no statistically significant differences in patient

Fig. 1  Patient distribution
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Table 1  Patient characteristics of intracorporeal and extracorporeal groups

Age (years)
Sex, N (%)

Ethnicity, N (%)

Race, N (%)

BMI
ASA Classification, N (%)

≥ 1 comorbidities, N (%)

Smoking status, N (%)

Previous intestinal surgery, N (%)
Indication for surgery, N (%)

ERP, N (%)

IA Group
(RRCIA + LRCIA)
N = 156

EA Group
(RRCEA + LRCEA)
N = 124

p value

Mean ± SD

64.6 ± 11.1

67.2 ± 11.1

Female
Male

73 (46.8%)
83 (53.2%)

72 (58.1%)
52 (41.9%)

0.05
0.06

Hispanic or Latino
Not Hispanic or Latino

19 (12.2%)
137 (87.8%)

3 (2.4%)
121 (97.6%)

Native American
Asian
Black
White
Other
Mean ± SD

2 (1.3%)
2 (1.3%)
11 (7.1%)
140 (89.7%)
1 (0.6%)
30.4 ± 7.2

0
4 (3.2%)
15 (12.1%)
100 (80.6%)
5 (4.0%)
29.6 ± 5.6

ASA Class 1
ASA Class 2
ASA Class 3
ASA Class 4

7 (4.5%)
58 (37.2%)
85 (54.5%)
6 (3.8%)
112 (71.8%)
86 (55.1%)
10 (6.4%)
4 (2.6%)
20 (12.8%)
8 (5.1%)
10 (6.4%)
8 (5.1%)
29 (18.5%)
4 (2.6%)
2 (1.3%)

4 (3.2%)
46 (37.1%)
60 (48.4%)
14 (11.3%)
102 (82.3%)
79 (63.7%)
6 (4.8%)
9 (7.3%)
20 (16.1%)
7 (5.6%)
6 (4.8%)
7 (5.6%)
22 (17.7%)
9 (7.3%)
2 (1.6%)

Never smoked
Past smoker
Current smoker

100 (64.1%)
43 (27.6%)
13 (8.3%)
54 (34.6%)

82 (66.1%)
32 (25.8%)
10 (8.1%)
36 (29.0%)

Benign neoplasm
Malignant neoplasm
Other

76 (48.7%)
79 (50.6%)
1 (0.6%)
100 (64.1%)

46 (37.4%)
76 (61.8%)
1 (0.8%)
81 (65.3%)

Hypertension
Myocardial infarction
Congestive heart failure
Coronary artery disease
Peripheral vascular disease
Cerebrovascular disease
COPD
Diabetes
Moderate/severe renal disease
Chronic steroid immunosuppressive use

0.003

0.05

0.30
0.33

0.04
–
–
–
–
–
–
–
–
–
–
0.9373

0.32
0.10

0.761

RRCIA robotic-assisted right colectomy intracorporeal anastomosis, LRCIA laparoscopic right colectomy intracorporeal anastomosis, RRCEA
robotic-assisted right colectomy extracorporeal anastomosis, LRCEA laparoscopic right colectomy extracorporeal anastomosis, BMI body mass
index, ASA American Society of Anesthesiologists, SD standard deviation of the mean, COPD chronic obstructive pulmonary disease, ERP
enhanced recovery pathway

demographics including sex, BMI, ASA classification,
smoking status, history of abdominal or intestinal surgery,
operative indication (benign or malignant neoplasia), and
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the use of enhanced recovery pathways. The EA group was
slightly older (mean age 67 vs. 65 years, p = 0.05), with
fewer white (81% vs. 90%, p = 0.05) and Hispanic ethnicity

Surgical Endoscopy

(2% vs. 12%, p = 0.003) patients. The EA group also had
more patients with overall comorbidities (82% vs. 72%,
p = 0.04), but none of the listed individual comorbidities
were statistically different between groups.

Operative outcomes
Intracorporeal anastomosis was associated with significantly longer mean operating room (208.5 vs. 175.5 min,
p < 0.0001) and mean operative times (157 vs. 118 min,
p < 0.0001 [Table 2]). Conversion was significantly lower
in IA patients compared to the EA group (0% vs. 5%,
p = 0.007). Of the 6 extracorporeal conversions, 5 were to
open and 1 to hand-assisted laparoscopy. The reasons for
conversion were abdominal adhesions (n = 4) and morbid
obesity (n = 2). Most of the extracorporeal anastomoses
were anti-peristaltic (87%) while most of the intracorporeal anastomoses were iso-peristaltic (95.5%).
The majority of extracorporeal specimen extraction
incisions were at the midline (100%), while 99% of the
intracorporeal specimen extraction incisions were located
off-midline (Pfannenstiel 78%, paramedian 4.5%, other
16%, and McBurney’s point 0.6%). Patients in EA group

had more concomitant procedures than patients in the IA
group [12% vs. 4%, p = 0.009 (Table 2)].
The mean extraction site incision length was significantly longer in the EA group (6.2 cm vs. 4.9 cm,
p ≤ 0.0001) compared to the IA group. Two patients in IA
group and one patient in EA group received intraoperative
blood transfusions. Only one patient in the IA group experienced an intraoperative complication, a bladder injury
that occurred while making a Pfannenstiel extraction site
incision. This injury was recognized immediately and easily repaired.

Postoperative outcomes
Table 3 shows postoperative outcomes prior to discharge.
Time to first flatus (1.5 vs. 1.8 days, p < 0.0001), time to first
bowel movement (1.6 vs. 2.0 days, p = 0.0005), and time to
soft/regular diet (1.2 vs. 1.6 days, p = 0.0014) were all significantly shorter in the IA group. Length of hospital stay was
significantly shorter in the IA group (median, 3 vs. 4 days,
p < 0.0001). There was no significant difference between
groups in discharge to home (IA 98.1% vs. EA 96.0%) or
discharge to an extended care facility (IA 1.9% vs. 0.8%).
There was 1 death in the EA group.

Table 2  Operative outcomes

OR time (min) (Wheels-in to Wheels-out)
Operative time (min) (Skin-to-skin)
Conversion, N (%)

Anastomosis, N (%)
Specimen Extraction, N (%)

Concomitant procedures, N (%)

Extraction Incision Length (cm)

Mean ± SD
Mean ± SD
To open
To hand-assisted lap
Iso-peristaltic
Anti-peristaltic
Midline
Off-Midline:
Pfannenstiel
McBurney's
Paramedian
Other
Unknown
General surgery
Colorectal
Mean ± SD [n]
Intraoperative blood transfusion, N (%)
Intraoperative complications, N (%)

IA Group
(RRCIA + LRCIA)
N = 156

EA Group
(RRCEA + LRCEA)
N = 124

p value

208.5 ± 55.9
156.9 ± 50.2
0
0
0
149 (95.5%)
7 (4.5%)
2 (1.3%)
154 (98.7%)
121 (77.6%)
1 (0.6%)
7 (4.5%)
25 (16.0%)
0
6 (3.8%)
6 (3.8%)
0
4.9 ± 1.4
2 (1.3%)
1 (0.6%)

175.5 (56.0), 124
118.2 ± 43.5
6 (4.8%
5 (4.0%)
1 (0.8%)
15 (12.1%)
108 (87.1%)
123 (100%)
0
0
0
0
0
1
15 (12.1%)
14 (11.3%)
1 (0.8%)
6.2 ± 3.6 [123]
1 (0.8%)
0

< 0.0001
< 0.0001
0.007

< 0.0001
< 0.0001
–
–
–
–
–
0.009

< 0.0001
> 0.99
–

RRCIA = robotic-assisted right colectomy intracorporeal anastomosis, LRCIA = laparoscopic right colectomy intracorporeal anastomosis,
RRCEA = robotic-assisted right colectomy extracorporeal anastomosis, LRCEA = laparoscopic right colectomy extracorporeal anastomosis
SD = standard deviation of the mean, OR = operating room, PACU = post-anesthesia care unit
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Table 3  Postoperative outcomes

Days to first flatus
Mean ± SD [n]
Days to first bowel movement
Mean ± SD [n]
Days to soft/regular diet
Mean ± SD [n]
Hospital LOS (days)
Mean ± SD [n]
Median (IQR)
Discharge status, N (%)
Home
Care facility
Death prior to discharge

p value

IA Group
(RRCIA + LRCIA)
N = 156

EA Group
(RRCEA + LRCEA)
N = 124

1.5 ± 1.0 [152]

1.8 ± 1.0 [121]

< 0.0001

1.6 ± 0.9 [153]

2.0 ± 1.1 [118]

0.0005

1.2 ± 25.2

1.6 ± 27.9 [123]

0.0014

4.2 ± 3.1
3.0 (3.0, 4.0)

4.4 ± 1.5 [122]
4.0 (3.0, 5.0)

153 (98.1%)
3 (1.9%)
0

119 (96.0%)
1 (0.8%)
1.0 (0.8%)

< 0.0001

0.46

RRCIA robotic-assisted right colectomy intracorporeal anastomosis, LRCIA laparoscopic right colectomy
intracorporeal anastomosis, RRCEA robotic-assisted right colectomy extracorporeal anastomosis, LRCEA
laparoscopic right colectomy extracorporeal anastomosis, SD standard deviation of the mean

Table 4 shows postoperative complications. There were
no significant differences in overall postoperative complications prior to discharge between groups (IA 10% vs. EA 8%,
p = 0.65). This lack of significant difference between groups
persisted at 14 days (IA 3% vs. EA 2%, p = 0.99) and 90 days
(IA 1% vs. EA 0%) after discharge. Anastomotic leaks (IA
0.6% vs. EA 0%), surgical site infections (1.3% vs. 0%),
hospital readmission (IA 2.6% vs. EA 0.8%, p = 0.387), and
reoperations (0.6% vs. 0%, p > 0.99) were also comparable
between groups.
Short-term oncologic outcomes are presented in Table 5.
Mean tumor size for malignant cases was 3.7 cm in the IA
group and 4.2 cm in the EA group (p = 0.225). There were
no significant differences in tumor location or TNM staging between groups. Mean lymph node harvest was 23 in
the IA group and 24 in the EA group (p = 0.535), with no
significant differences in mean number of positive lymph
nodes (1.4 vs. 1.6, p = 0.403), respectively. Of those with
malignant disease who received adjuvant chemotherapy
(IA 29% vs. EA 33%, p = 0.605), there were no significant
delays in starting treatment, with a mean time from surgery
to chemotherapy of 40 days (IA group) versus 46 days (EA
group) (p = 0.277).

Discussion
This prospective, multi-center, comparative study across
20 institutions comparing intracorporeal and extracorporeal anastomoses for robotic assisted and laparoscopic right
colectomy for benign and malignant disease demonstrated
significant advantages with the intracorporeal approach
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showing fewer conversions to open surgery, shorter extraction site incision, shorter time to gastrointestinal recovery,
and shorter length of hospital stay. The IA technique was
associated with longer operative times when compared to the
EA approach. Postoperative complications were comparable
between the two groups.
Previous studies have confirmed advantages with IA.
Four meta-analyses have shown shorter time to return of
bowel function, shorter length of hospital stay, and less
postoperative morbidity with IA when compared to EA
[6, 8–10]. Although the mechanism by which bowel function recovers faster in IA patients is unknown, hypotheses
include less bowel manipulation and dissection and a predominance of iso-peristaltic anastomoses with the intracorporeal technique. Length of hospital stay is a parameter that
is influenced by patient and non-patient factors and the use
of enhanced recovery pathways. Recovery of bowel function
has been reported to be shorter for IA in retrospective studies, although other smaller, retrospective, single-institution
studies have also shown no difference when compared to EA
[6, 8, 11–13]. In the present study, there was no significant
difference in the use of enhanced recovery pathways (IA
64% vs. EA 65%, p = 0.761).
A randomized controlled trial of 140 patients comparing
laparoscopic IA and EA found that operative time was significantly longer in the IA group and that time to gastrointestinal recovery, ileus, and postoperative complications were
significantly less in the IA group [11]. In contrast to our
study, the number of patients in this randomized trial was
smaller and all patients underwent a laparoscopic approach.
The primary outcome was length of hospital stay, which was
longer than typically expected for minimally invasive right

Surgical Endoscopy
Table 4  Postoperative
complications
Postoperative complications to d ischargea, N (%)
Gastrointestinal
Ileus
Anastomotic leakage
Bowel obstruction
Bleeding requiring intervention
Wound
Superficial SSI
Wound dehiscenceb
Cardiac
Pulmonary
Genitourinary
Complicationsa: discharge to 2 weeks, N (%)
Gastrointestinal
Deep SSI
Wound
Genitourinary
Readmissions, N (%)
Reoperations, N (%)

IA Group
(RRCIA + LRCIA)
N = 156

EA Group
(RRCEA + LRCEA)
N = 124

p value

15 (9.6%)
8 (5.1%)
7 (4.5%)
1 (0.6%)
0
3 (1.9%)
2 (1.3%)
2 (1.3%)
0
1 (0.6%)
1 (0.6%)
3 (1.9%)
5 (3.2%)
2 (1.3%)
0
1 (0.6%)
1 (0.6%)
4 (2.6%)
1 (0.6%)

10 (8.1%)
3 (2.4%)
2 (1.6%)
0
1 (0.8%)
2 (1.6%)
1 (0.8%)
0
1 (0.8%)
1 (0.8%)
1 (0.8%)
4 (3.2%)
3 (2.4%)
1 (0.8%)
1 (0.8%)
0
1 (0.8%)
1 (0.8%)
0 (0.0%)

0.6512
–
–
–
–
–
–
–
–
–
–
–
> 0.99
–
–
–
–
0.3869
> 0.99

RRCIA robotic-assisted right colectomy intracorporeal anastomosis, LRCIA laparoscopic right colectomy
intracorporeal anastomosis, RRCEA robotic-assisted right colectomy extracorporeal anastomosis, LRCEA
laparoscopic right colectomy extracorporeal anastomosis, SSI surgical site infection

a

b

Complications requiring invasive intervention
At specimen extraction site

colectomy (IA 5.7 days vs. EA 6.6 days, p = 0.194). The
incision length for both groups was also unusually long and
significantly different (IA 6.7 cm vs. EA 8.7 cm, p < 0.001).
Incision length in our study was also significantly different
between groups in favor of the IA technique (IA 4.9 cm vs.
EA 6.2 cm, p < 0.0001).
Other studies have also suggested that IA is associated
with fewer complications than EA [14, 15]. In a retrospective propensity score-matched analysis of 1029 patients, IA
showed advantages in conversion, length of hospital stay,
and postoperative complications [16]. It is possible that the
IA technique, especially with the laparoscopic approach,
requires a skill set that decreases the risk for conversion
during the colon and mesentery mobilization parts of the
procedure. Also, EA conversion may occur when extension of the extraction site incision is necessary to enable
transverse colon reach, an operative step that is not part of
the IA technique. Our study showed a significantly shorter
length of hospital stay for the IA group that was not related
to the incidence of ileus. Although not statistically significant, the incidence of ileus was higher in the IA than in
the EA group (4.5% vs. 1.6%). Differences in institutional
ERP methods and discharge criteria can impact length of
hospital stay. ERP was included in the statistical model but

standardized discharge criteria were not and this may be
considered a study limitation. Our current prospective study
did not confirm an advantage of IA in postoperative complications, although the overall number of complications was
low. Comparable to the larger retrospective study mentioned
above, operative times for IA were longer compared to EA.
Laparoscopic IA is not a common minimally invasive
operative approach choice given the skills required to accomplish this technique. The robotic approach has increased the
adoption of IA due to the benefits of endowrist articulated
instruments that permit precise dissection, suturing, and
stapling with seven degrees of freedom, allowing IA to be
amenable to more surgeon skill sets than the laparoscopic
counterpart. The degree of difficulty of the sutured laparoscopic anastomosis has limited the widespread adoption of
this approach and may be the reason for lower IA technique
study numbers in many studies, as was the case in ours [12].
In a randomized clinical trial by Park et al., [17] comparing
the short-term outcomes of robotic assisted versus standard
laparoscopic right colectomy, IA was performed more often
with the robotic-assisted approach, whereas EA was more
often performed with the laparoscopic technique. Our study
design took into account the anticipated difficulties recruiting laparoscopic surgeons accruing laparoscopic IA cases.
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Table 5  Pathologic and
adjuvant therapy outcomes for
malignant neoplasia cases

Tumor size (cm)
Mean ± SD [n]
TNM stage, N (%)
Stage 0
Stage I
Stage II
Stage III
Stage IV
Tumor Location, N (%)
Cecum
Ascending colon
Hepatic flexure
Transverse colon
Terminal Ileum
Lymph node harvest
Mean ± SD [n]
Number lymph nodes positive
Mean ± SD [n]
Adjuvant chemotherapy, N (%)
Time to chemotherapy (days)
Mean ± SD [n]

IA Group
(RRCIA + LRCIA) N = 90

EA Group
(RRCEA + LRCEA) N = 81

p value

3.7 ± 2.3 [89]

4.2 ± 2.5 [80]

0.225

0
28 (31.5%)
19 (12.2%)
39 (43.8%)
3 (3.3%)

4 (4.9%)
22 (27.2%)
18 (14.5%)
33 (40.7%)
4 (4.9%)

0.8004

47 (52.2%)
30 (33.3%)
10 (11.1%)
2 (2.2%)
1 (1.1%)

34 (42.0%)
38 (46.9%)
5 (6.2%)
4 (4.9%)
0

0.1801

23.3 ± 10.0 [89]

24.2 ± 9.5 [81]

0.535

1.4 ± 2.7 [89]
26 (29.2%)

1.6 ± 5.5 [81]
26 (32.9%)

0.403
0.605

39.8 ± 14.5 [26]

46.0 ± 20.2 [26]

0.277

RRCIA robotic-assisted right colectomy intracorporeal anastomosis, LRCIA laparoscopic right colectomy
intracorporeal anastomosis, RRCEA robotic-assisted right colectomy extracorporeal anastomosis, LRCEA
laparoscopic right colectomy extracorporeal anastomosis

The strength of this multi-center comparative study is
that the results may be generalizable and representative of
the real-world setting. It validates prior single-institution
studies published by MIS experts. There are some limitations. Patients with ileocecal Crohn’s disease benefit from a
minimally invasive approach but outcomes for these patients
with nutritional deficits and on immunosuppressive medications may be different than for benign and malignant
neoplasia. We chose to concentrate on a relatively uniform patient population to compare IA and EA and therefore excluded patients with Crohn’s disease. We could not
control for preoperative interventions, such as mechanical
bowel preparation and the specific elements of enhanced
recovery pathways, and there was no unified method for diet
resumption across all centers. We reviewed the significant
differences in patient demographics shown in Table 1 and
these may be attributed to regional population distribution
differences that were unlikely to contribute significantly to
clinical outcomes alone. The study design did not account
for racial differences. This study involved an uncommonly
higher number of institutions and surgeons, which may have
contributed to increased variability and data heterogeneity,
although this was necessary to accrue the number of patients
for each group in a reasonable amount of time. Although
experienced minimally invasive surgeons were instructed
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to adhere to IA and EA principles, they were limited to one
technique and 20 cases total to allow homogeneous and balanced case contributions per surgeon and institution. We did
not choose a randomized controlled design so that surgeons
would not perform operations uncommon to their practice,
such as laparoscopic IA. Also, we could not control for the
degree of intracorporeal mobilization prior to extracorporeal
extraction.
This study demonstrates significant advantages for the
IA compared to the EA technique, whether the approach
is laparoscopic or robotic. These data validate the value of
minimally invasive right colectomy and the benefits of the
IA technique. Further studies comparing laparoscopic versus
robotic-assisted IA may be warranted and should focus on
operative proficiency and the benefits of iso- versus antiperistaltic anastomotic orientation.

Conclusion
In this prospective multi-center study of minimally invasive right colectomy across 20 institutions, IA was associated with significant improvements in short-term outcomes
including conversion to open surgery, quicker return of
bowel function, and shorter length of hospital stay. Operative

Surgical Endoscopy

times were significantly longer in the IA group. These outcome advantages support current and future training programs preparing surgeons in the adoption of intracorporeal
minimally invasive surgery techniques.
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